Released on: October 10, 2008, 2:29 am

Press Release Author: Shushmul Maheshwari

Industry: Pharmaceuticals

Press Release Summary: RNCOS has recently added a new Market Research Report titled,
"Global Vaccine Market Forecast to 2012" to its report gallery. Our report gives an
extensive and objective analysis on the global market for vaccines.

Press Release Body: RNCOS has recently added a new Market Research Report titled,
"Global Vaccine Market Forecast to 2012" to its report gallery. The report states
that vaccines, which were earlier thought as a low margin, low growth industry, have
emerged as one of the most lucrative segments in the pharmaceutical industry. With a
projected CAGR growth of over 16% in the next five years, the industry will emerge
as the fastest growing therapy area. The US and Europe represents the two largest
vaccine markets (in fact, these tow countries were the largest markets in 2007) and
will continue to experience healthy growth in future.

Segment-wise, pediatric vaccines presently dominate the global vaccine market but
adult vaccine segments will define the future direction of growth. The cancer
vaccine market, led by cervical cancer vaccines, is presently one of the most
lucrative areas for vaccine manufacturers. Overall, cancer vaccines are expected to
account for nearly 27% of the total vaccine revenues by 2012.

Owing to lower margins and the mature nature of these markets, the basic and
enhanced pediatric markets are expected to show stagnant growth in future. On the
other hand, launch of a number of new vaccines will make the addiction, cancer and
proprietary pediatrics/adolescent vaccine market highly dynamic. On a whole, the
global vaccine market is expected to register revenues in excess of US$ 30 Billion
by 2012.

Analysis of the competitive landscape of the market shows its highly concentrated
structure, with the top four players accounting for over 86% of the total market in
2007.

Our report gives an extensive and objective analysis on the global market for
vaccines. It investigates both the past and current trends in the vaccine market,
and outlines the future trends shaping the industry. It comprehensively assesses the
performance of vaccines, both in the market and in developing stage. Based on
various present and future indicators, the report evaluates the prospects of various
vaccine segments. The report can thus give valuable information for
manufacturers/investors preparing to enter in these vaccine segments.

Our report provides forecast on

- Global vaccine revenues
- Basic pediatrics revenues
- Enhanced pediatrics revenues
- Proprietary pediatrics/adolescent revenues
- Adult/travel revenues
- Influenza revenues
- Cancer vaccines revenues
- Major pediatric and adult vaccines
- Major geographical markets - US, Europe, China, India, Japan and Brazil
- US pediatric and adult vaccine markets
- Revenues of key players
- Revenues of key vaccine brands

Profiling on Key Players

This section gives a category-wise overview on the key players, including
Sanofi-Aventis, GlaxoSmithKline and Novartis, operating in the global vaccine
market. It provides vital information, like business overview, current performance,
future prospects of key vaccine brands and major merger and acquisitions by the key
players to give a rational overview on the competitive landscape of the market.

About RNCOS:

RNCOS, incorporated in the year 2002, is an industry research firm. It has a team of
industry experts who analyze data collected from credible sources. They provide
industry insights and analysis that helps corporations to take timely and accurate
business decision in today's globally competitive environment.

For more information visit: http://www.rncos.com/Report/IM153.htm
Current Industry News: http://www.rncos.com/Blog/

Web Site: http://www.rncos.com/

Contact Details: 29, 1st Floor, Patparganj Industrial Area, Delhi 92
91-11-4214-1229
91-11-4214-1228
info@rncos.com

http://www.rncos.com/

press@rncos.com